Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell W Jenkins

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Cancer Immunology Research|April 13, 2016
Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic InflammationShenghong Yang, Yu Imamura, Russell W Jenkins, et al.
Lab on a Chip|September 6, 2018
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockadeAmir R Aref, Marco Campisi, Elena Ivanova, et al.
Nature Communications|August 27, 2024
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trialMeghan J Mooradian, Florian J Fintelmann, Thomas J LaSalle, et al.
Neuro-Oncology|December 15, 2025
Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular ImmunotherapyEric P Grewal, Samuel J Steuart, Baolin Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung CancerShuai Li, Shengwu Liu, Jiehui Deng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2025
Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunityTaral R Lunavat, Lisa Nieland, Sanne M van de Looij, et al.
Cancer Immunology Research|January 9, 2025
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor SpheroidsYi Sun, Luke Maggs, Apekshya Panda, et al.
Nature Biomedical Engineering|February 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumoursJanina Dörr, Lisa Gregor, Sebastian B Lacher, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunityTaral R Lunavat, Lisa Nieland, Sanne M van de Looij, et al.
The Journal of Clinical Investigation|November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, Andrew Portell, Elena V Ivanova, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Cancer Immunology Research|April 13, 2016
Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic InflammationShenghong Yang, Yu Imamura, Russell W Jenkins, et al.
Lab on a Chip|September 6, 2018
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockadeAmir R Aref, Marco Campisi, Elena Ivanova, et al.
Nature Communications|August 27, 2024
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trialMeghan J Mooradian, Florian J Fintelmann, Thomas J LaSalle, et al.
Neuro-Oncology|December 15, 2025
Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular ImmunotherapyEric P Grewal, Samuel J Steuart, Baolin Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung CancerShuai Li, Shengwu Liu, Jiehui Deng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2025
Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunityTaral R Lunavat, Lisa Nieland, Sanne M van de Looij, et al.
Cancer Immunology Research|January 9, 2025
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor SpheroidsYi Sun, Luke Maggs, Apekshya Panda, et al.
Nature Biomedical Engineering|February 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumoursJanina Dörr, Lisa Gregor, Sebastian B Lacher, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunityTaral R Lunavat, Lisa Nieland, Sanne M van de Looij, et al.
The Journal of Clinical Investigation|November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, Andrew Portell, Elena V Ivanova, et al.
Pageof 8